Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III by Van Hemelrijck, Mieke et al.
Calcium Intake and Serum Concentration in Relation to
Risk of Cardiovascular Death in NHANES III
Mieke Van Hemelrijck1, Karl Michaelsson2, Jakob Linseisen3, Sabine Rohrmann4*
1Cancer Epidemiology Group, Division of Cancer Studies, School of Medicine, King’s College London, London, United Kingdom, 2Department of Surgical Sciences,
Uppsala University, Uppsala, Sweden, 3 Institute of Epidemiology I, Helmholtz Zentrum Mu¨nchen, Neuherberg, Germany, 4 Institute of Social and Preventive Medicine,
University of Zurich, Zurich, Switzerland
Abstract
Background: Evidence for an association between calcium intake and risk of cardiovascular death remains controversial. By
assessing dietary intake, use of supplements, and serum levels of calcium, we aimed to disentangle this link in the third
National Health and Nutrition Examination Survey (NHANES III).
Methods: Mortality linkage of NHANES III to death certificate data for those aged 17 years or older (n = 20,024) was used to
estimate risk of overall cardiovascular death as well as death from ischemic heart disease (IHD), acute myocardial infarction
(AMI), heart failure (HF), and cerebrovascular disease (CD) with multivariate Cox proportional hazards regression analysis.
Results: About 10.0% of the population died of cardiovascular disease and the majority (5.4%) died of IHD. There was
increased risk of overall CVD death for those in the bottom 5% of serum calcium compared to those in the mid 90% (HR:
1.51 (95% CI: 1.03–2.22)). For women there was a statistically significant increased risk of IHD death for those with serum
calcium levels in the top 5% compared to those in the mid 90% (HR: 1.72 (95%CI: 1.13–2.61)), whereas in men, low serum
calcium was related to increased IHD mortality (HR: 2.32 (95% CI 1.14–3.01), Pinteraction: 0.306). No clear association with CVD
death was observed for dietary or supplemental calcium intake.
Conclusions: Calcium as assessed by serum concentrations is involved in cardiovascular health, though differential effects
by sex may exist. No clear evidence was found for an association between dietary or supplementary intake of calcium and
cardiovascular death.
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Introduction
A large number of studies have investigated the potential link
between serum calcium levels and cardiovascular death
[1,2,3,4,5,6,7,8]. Already in 1996, Reunanen and colleagues [7]
found an increased risk of premature death in men (,50 years)
with increasing serum calcium levels. They examined mortality
rate in relation to a single serum calcium measurement obtained at
screening of 33,346 persons during a mean follow-up period of
10.8 years [7]. In contrast, a meta-analysis focused on chronic
kidney disease patients found no association between all-cause
mortality and serum levels of calcium [6], but a German
prospective study of 1206 patients with coronary heart disease
found a strong positive association between serum calcium and all-
cause mortality [1].
Calcium supply is usually assessed through evaluation of
calcium intake via diet or supplements. A recent study by Li and
colleagues, using data from the Heidelberg cohort of the European
Prospective Investigation into Cancer and Nutrition (EPIC),
showed no association between dietary intake of calcium or use
of calcium supplements and cardiovascular mortality [9]. These
findings were in conjunction with what was found in another large
prospective study [10], but a Swedish population-based prospec-
tive study of men with relatively high intakes of dietary calcium
showed a reduction in all-cause mortality when taking more than
the recommended daily amount [11]. With respect to calcium
supplementation, Bolland and colleagues reanalyzed the Women’s
Health Initiative Calcium/Vitamin D Supplementation Study
(WHI CaD Study) based on 36,282 postmenopausal women and
found no statistically significant association of calcium supplements
with cardiovascular death [12]. In a related meta-analysis, the
authors combined clinical trials comparing calcium supplements
versus placebo and found no association with overall death [12].
Nevertheless, the majority of studies focused on women and few
studies investigated different types of cardiovascular death or a
dose-response relationship [9,12,13,14,15,16]. The most recently
published study from the National Institutes of Health –AARP
Diet and Health Study showed that during a mean follow-up time
of 12 years, there was an excess risk of CVD death related to high
intake of supplemental calcium in men, but not in women [8].
Thus, the current evidence for an association between calcium
supply, serum calcium levels and risk of cardiovascular death
remains controversial. Calcium is not only required for contraction
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Table 1. Baseline characteristics of study population by vital status.
Death due to:
No death Any CVD IHD Acute MI Heart Failure Cerebr Disease
(ICD10:I00–I99)
(ICD10: I20–
I25) (ICD10:I21–22) (ICD10: I50) (ICD10: I60–69)
N(%) 16844 (90.01) 1870 (9.99) 1006 (5.38) 362 (1.93) 133 (0.71) 352 (1.88)
Mean age (SE), years 40.65 (0.35) 68.85 (0.73) 68.68 (0.78) 65.51 (1.16) 74.02 (1.43) 69.43 (1.91)
Sex
Men 47.46 45.72 50.69 56.00 41.00 36.50
Women 52.54 54.28 49.31 44.00 59.00 63.50
Race-Ethnicity
Non-Hispanic white 75.10 82.49 83.61 85.16 87.26 81.09
Non-Hispanic black 11.24 11.32 9.95 8.64 9.89 12.39
Mexican American 5.49 2.55 2.52 2.39 1.06 3.17
Other 8.18 3.64 3.92 3.80 1.79 3.34
Poverty to income ratio
,1.4 19.18 27.23 26.89 35.95 30.33 22.71
1.4–3.17 34.42 35.73 35.88 36.17 38.14 36.99
$3.17 46.40 37.04 37.23 37.88 31.53 40.31
Mean follow-up time (SE), months 173.29 (2.67) 98.74 (2.71) 97.14 (2.37) 98.57 (4.22) 115.42 (5.32) 95.22 (6.44)
Ionized serum calcium, mmol/L
Mean (SE) 1.24 (0.003) 1.23 (0.004) 1.23 (0.004) 1.23 (0.005) 1.23 (0.007) 1.23 (0.008)
Bottom 5% (,1.16) 3.17 6.04 7.54 5.91 3.36 3.26
Mid 90% (1.16–1.31) 91.56 86.70 84.58 86.87 93.88 87.94
Top 5% (1.31+) 5.27 7.26 7.89 7.27 2.76 8.80
Dietary calcium intake (SE), mg
,500 30.33 37.77 38.97 38.08 39.51 33.45
500–1000 38.55 40.62 41.01 42.67 40.62 44.13
1000–1300 13.47 11.83 11.94 10.43 8.01 12.67
.1300 17.65 9.78 8.06 8.82 11.85 9.76
Calcium supplement users 19.31 18.14 18.09 16.36 20.54 18.91
Daily supplemental calcium intake, mg
0 79.37 81.10 81.21 82.75 79.46 80.36
0–500 17.41 14.77 15.04 12.40 13.11 15.51
500–1000 2.24 2.74 2.53 3.93 4.23 3.61
1000–2000 0.81 1.20 1.21 0.92 3.20 0.52
$2000 0.17 0.20 0.00 0.00 0.00 0.00
How often supplement taken per month (SE) 6.86 (0.34) 6.72 (0.54) 6.54 (0.76) 6.31 (1.18) 8.36 (2.74) 6.53 (1.28)
Total calcium intake
,500 30.21 42.86 42.44 40.29 51.26 39.87
500–1000 36.10 35.40 37.03 38.32 30.22 36.86
1000–1300 13.53 10.76 11.30 10.39 6.28 11.78
1300–2000 14.57 8.09 6.02 8.53 8.07 10.90
.2000 5.60 2.87 3.21 2.48 4.17 0.59
History of Hypertension 34.23 76.21 75.68 71.03 78.36 77.33
History of Diabetes 3.95 14.14 16.10 19.79 9.42 12.78
Mean Serum Vitamin D (SD), ng/mL 29.87 (0.36) 26.43 (0.42) 26.52 (0.61) 27.30 (0.95) 26.33 (1.42) 26.86 (1.00)
Comorbidity Index
0 0.53 0.03 0.01 0.00 0.00 0.07
1 67.03 34.06 33.91 33.78 39.58 36.27
2 24.16 40.12 40.82 40.54 38.53 34.60
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and relaxation of heart muscles, but is also a second messenger in
signal transduction pathways of the cardiovascular system. An
imbalance of normal calcium homeostasis has been linked to both
heart failure and hypertension, but a complex array of mecha-
nisms still needs to be disentangled [17]. By assessing dietary
intake, use of supplements, as well as serum levels of calcium, we
aimed to study this link in the third National Health and Nutrition
Examination Survey (NHANES III) by evaluating overall cardio-
vascular death as well as death due to ischemic heart disease
(IHD), acute myocardial infarction (AMI), heart failure (HF), and
cerebrovascular disease (CD) in both men and women.
Methods
Study population and data collection
The NHANES III Mortality linkage provides follow-up data
from the date of NHANES III survey participation (1988–1994)
through December 31, 2006. The latter is a cross-sectional study
conducted by the National Center for Health Statistics (NCHS)
between 1988 and 1994 [18] and was designed as a multistage
stratified, clustered probability sample of the US civilian non-
institutionalized population at least two months old. The included
subjects participated in an interview conducted at home and an
extensive physical examination, which included a blood sample,
taken in a mobile examination center and participants were
randomly assigned to participate in either the morning or
afternoon/evening examination session [18]. In total, 30,818
people were interviewed in NHANES III and had a physical
examination and a blood sample taken. The NCHS has updated
the mortality linkage of NHANES III to death certificate data
obtained in the National Death Index (NDI) such that mortality
ascertainment is based on results of a probabilistic match between
NHANES III and NDI death certificate records [19]. From this
linkage, we selected all men and women eligible for mortality
follow-up (all participants 17 years or older), who did not have a
history of heart disease (n = 18,714).
Ionized serum calcium was quantified with NOVA 7 analyzer
(Nova Biomedical, Waltham, MA), a Hitachi 737 Analyzer
(Boehringer Mannheim Diagnostics, Indianapolis, IN) [20,21].
Since calcium is tightly regulated we categorized ionized serum
calcium based on the cut-offs for the bottom 5% and top 5%, i.e.
,1.16, 1.16–1.31, 1.31+ mmol/L which is consistent with what is
indicated in the literature as normal ionized serum calcium [22].
Dietary calcium was evaluated in all individuals with one 24-h
dietary recall. A validation study involving a repeated 24-h recall
for 5% of the respondents showed that the correlation between the
two measurements was 0.46 for men and 0.40 for women,
suggesting a moderate day-to-day variation in calcium intake
[23,24]. Using the recommended dietary allowance of 1000–
1300 mg per day as a reference [25], we categorized daily dietary
calcium intake as follows: ,500, 500–1000, 1000–1300,
.1300 mg. Calcium supplements were calculated based on the
information obtained in the vitamin/mineral supplementation
questionnaires, which provide information on the dietary supple-
ment code and daily dosage. By merging this information with the
Supplement Concentrations documentation provided by
Table 1. Cont.
Death due to:
No death Any CVD IHD Acute MI Heart Failure Cerebr Disease
(ICD10:I00–I99)
(ICD10: I20–
I25) (ICD10:I21–22) (ICD10: I50) (ICD10: I60–69)
N(%) 16844 (90.01) 1870 (9.99) 1006 (5.38) 362 (1.93) 133 (0.71) 352 (1.88)
3+ 8.27 25.78 25.26 25.68 21.89 29.06
Alcohol consumption
Never 43.64 63.81 63.19 66.80 64.76 64.61
Up to once a week 20.00 14.59 13.57 15.92 24.58 14.11
2–3 times a week 14.49 4.25 4.77 4.69 2.65 3.59
4–6 times a week 12.06 5.27 5.32 3.62 2.96 4.39
Daily or more 9.81 12.09 13.16 8.96 5.06 13.29
Smoking behaviour
Never 48.20 43.89 43.37 40.11 54.43 47.86
Former 23.14 32.72 30.81 32.80 28.18 34.14
Current 28.66 23.39 25.83 27.08 17.39 18.00
Vigorous Physical activity 9.54 26.28 26.89 26.81 32.86 26.83
Total energy intake (SE), kcal 2257.18 (18.67) 1729.61 (28.85) 1721.82 (35.87) 1697.40 (66.03) 1686.41 (86.78) 1661.49 (70.67)
BMI (kg/m2)
,18.50 2.79 3.25 2.83 1.12 5.03 3.19
18.50–24.99 45.02 36.58 37.16 34.64 35.38 39.87
25.00–25.99 31.41 33.39 32.64 36.93 31.52 34.26
.30.00 20.78 26.78 27.37 27.31 28.07 22.68
Mean Waist circumference (SE), cm 90.46 (0.26) 97.78 (0.66) 98.28 (0.86) 98.50 (1.17) 96.95 (2.06) 95.25 (1.37)
Mean CRP (SE), mg/L 3.85 (0.09) 6.06 (0.30) 6.10 (0.49) 4.68 (0.44) 6.51 (0.84) 6.30 (0.82)
doi:10.1371/journal.pone.0061037.t001
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NHANES III, we estimated the mean daily dosage of calcium per
individual. In addition to a dichotomous covariate indicating
whether a person took any calcium supplementation or not, we
categorized calcium supplement intake using 2000 mg as the
maximum tolerable dosage [25] (i.e. ,500, 500–1000, 1000–
2000, 2000+mg) and also quantified how often a supplement was
taken per month. Due to sample size issues, the first two groups of
calcium supplement intake were combined for the stratified
analyses. Finally, we calculated to the total daily calcium intake
by adding the dietary and supplement intake of calcium per day.
The information was categorized as ,500, 500–1000, 1000–1300,
1300–2000, and .2000 mg with 1000–1300 mg/day as the
reference.
Other covariates in the analysis included age, race/ethnicity,
poverty-to-income-ratio, comorbidity index, smoking, alcohol
consumption, physical activity, serum vitamin D, total energy
intake (kcal), body mass index (BMI), waist circumference, and
serum C-reactive protein (CRP). Race and ethnicity were
combined into four race–ethnic groups: Non-Hispanic white,
Non-Hispanic black, Mexican American and Other. The poverty
to income ratio is an index of poverty status which is calculated by
dividing family income by a poverty threshold specific to family
size. Comorbidity was evaluated with a comorbidity coefficient
similar to the Charlson Comorbidity Index (CCI), as used in other
NHANES III-based analyses [26]. Each of the comorbidities (i.e.,
history of heart attack, congestive heart failure, diabetes,
hypertension, etc.) available in the dataset contributed one point
to the composite index with additional points given for older age.
Cigarette smoking, alcohol consumption, physical activity, and
total energy intake were assessed using questionnaires. 25-hydroxy
vitamin D was measured using the Diasorin radioimmunoassay kit
(Diasorin, Stillwater, MN, USA) on frozen serum from 1994 to
1995. Coefficients of variations from quality control samples
ranged from 13% to 19%. The radioimmunoassay kit was
calibrated using high-performance liquid chromatographically
purified vitamin D every six months. Body mass index (BMI)
was calculated as weight in kilograms divided by the square of
height in meters. The first was measured to the nearest 0.01 kg
with an electronic digital scale while the participant was wearing
foam slippers and paper shirt and trousers, whereas height was
measured to the nearest 0.1 cm using a stadiometer. Waist
circumference was measured at the iliac crest to the nearest
0.1 cm. Finally, serum CRP, an established inflammatory
biomarker, was measured using a low sensitivity method that
can detect levels .3.0 mg/L [27]. The protocols for the conduct
of NHANES III were approved by the institutional review board
Table 2. Hazard Ratios and 95%Confidence Intervals for risk of cardiovascular death by serum, dietary, supplement, and total
calcium.
Hazard Ratios and 95%Confidence Intervals (CI) for Death due to:
Any CVD IHD Acute MI Heart Failure Cerebr Disease
(ICD10:I00–I99) (ICD10: I20–I25) (ICD10:I21–22) (ICD10: I50) (ICD10: I60–69)
Ionized serum calcium1, mmol/L
,1.16 1.51 (1.03–2.22) 1.94(1.27–2.94) 1.67 (0.86–3.20) 0.64 (0.15–2.67) 0.81 (0.38–1.71)
1.16–1.31 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref)
1.31+ 1.16 (0.85–1.58) 1.32 (0.96–1.81) 1.23 (0.71–2.11) 0.40 (0.14–2.20) 1.35 (0.67–2.72)
Dietary calcium intake2 (SE), mg
,500 1.03 (0.75–1.41) 1.13 (0.74–1.71) 1.32 (0.76–2.30) 1.61 (0.59–4.37) 0.79 (0.37–1.68)
500–1000 0.98 (0.76–1.26) 1.01 (0.69–1.46) 1.20 (0.80–1.79) 1.40 (0.52–3.73) 0.96 (0.53–1.74)
1000–1300 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref)
.1300 0.90 (0.59–1.35) 0.71 (0.38–1.31) 0.80 (0.41–1.55) 1.75 (0.45–6.83) 0.87 (0.37–2.07)
Calcium supplement users2 (versus no
supplements)
0.84 (0.67–1.04) 0.88 (0.68–1.14) 0.85 (0.56–1.31) 0.81 (0.32–2.01) 0.79 (0.45–1.36)
Daily supplemental calcium intake2, mg
0 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref)
0–500 0.85 (0.66–1.09) 0.90 (0.68–1.19) 0.80 (0.46–1.37) 0.71 (0.25–2.06) 0.81 (0.50–1.32)
500–1000 0.71 (0.49–1.13) 0.73 (0.40–1.32) 1.23 (0.53–2.82) 0.51 (0.07–4.01) 0.81 (0.20–3.20)
1000–2000 0.92 (0.59–1.44) 0.95 (0.42–2.15) 1.15 (0.37–3.54) 2.64 (0.57–12.13) 0.42 (0.08–2.16)
$2000 1.62 (0.27–9.75) NA NA NA NA
Total daily calcium intake, mg
,500 1.07 (0.77–1.49) 1.07 (0.71–1.61) 1.30 (0.76–2.22) 1.89 (0.70–5.13) 0.86 (0.47–1.56)
500–1000 1.07 (0.82–1.38) 1.08 (0.75–1.56) 1.34 (0.87–1.76) 1.54 (0.59–4.05) 1.00 (0.59–1.69)
1000–1300 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref)
1300–2000 0.86 (0.59–1.25) 0.60 (0.35–1.03) 0.91 (0.42–1.95) 1.51 (0.40–5.68) 1.04 (0.49–2.25)
.2000 1.01 (0.52–1.95) 1.07 (0.44–2.58) 0.82 (0.34–1.96) 2.43 (0.50–11.91) 0.19 (0.05–0.76)
1Adjusted for: age, sex, race/ethnicity, poverty to income ratio, comorbidity index, serum vitamin D, alcohol consumption, smoking behaviour, vigorous physical activity,
and BMI.
2Adjusted for: age, sex, race/ethnicity, poverty to income ratio, comorbidity index, serum vitamin D, alcohol consumption, smoking behaviour, vigorous physical activity,
total energy intake, and BMI.
doi:10.1371/journal.pone.0061037.t002
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of the NCHS, Centers for Disease Control and Prevention.
Written informed consent was obtained from all participants [27].
Data analysis
The association between dietary calcium intake and serum
ionized calcium as well as the association between calcium
supplement intake and serum ionized calcium was evaluated
using a linear regression model adjusted for age and sex. Sampling
weights for NHANES III were used to account for sampling
variability and to adjust for differential probability of selection of
persons [18]. To evaluate the association between different
measurements of calcium (serum, dietary intake, and supplements)
in relation to cardiovascular death, we used multivariate Cox
proportional hazards regression. Cardiovascular death (CVD) was
defined by ICD-10: I00–I99, and was subdivided into IHD (ICD-
10: I20–25), AMI (ICD-10: I21–22), HF (ICD-10: 50), and CD
(ICD-10: I60–69). All models were adjusted for age, sex, race/
ethnicity, poverty to income ratio, comorbidity index, smoking,
alcohol consumption, physical activity, BMI, and serum vitamin
D. The models for dietary and supplement calcium intake were
also adjusted for total energy intake. Stratified analyses were
conducted for men and women, as well as for levels of vitamin D
(,/$20 ng/mL [28]). We tested for interaction of calcium
measurements with sex or vitamin D concentration using an
interaction term for the respective categorical variables. The latter
stratification was performed since vitamin D deficiency has been
linked to cardiovascular disease and has a key role in calcium
homeostasis [29,30]. Due to small number of events these stratified
analyses were only performed for overall CVD and IHD death. To
graphically display Hazard Ratios (HRs) representing the dose-
response association for daily intake of calcium supplements and
cardiovascular death, we used the Restrictive Cubic Spline (RCS)
function of daily calcium supplement and dietary intake with 4
knots (0.05, 0.35, 0.65, and 0.95 percentile [31]) in a multivariate
Cox proportional hazards model as described above. This analysis
was performed using the RCS_Reg SAS Macro created by
Desquilbet and Mariotti [32]. All tests were two-sided; p-values
,0.05 were considered to be statistically significant. All analyses
were conducted with Statistical Analysis Systems (SAS) release 9.2
(SAS Institute, Cary, NC).
Results
About 10.0% of the population died of cardiovascular disease
and the majority (4.9%) died of IHD. All baseline characteristics of
the study population are shown in Table 1.
The majority of deaths occurred among non-Hispanic whites
(82.5%). The poverty-to-income ratio was rather equally distrib-
uted among those who died, with slightly smaller proportion of
people in the lowest tertile of the ratio (27.2%). The proportion of
people with serum calcium in the bottom or top 5% was higher for
those who died of cardiovascular disease compared to those who
did not (Table 1).
When put together in the same age- and sex-adjusted model,
neither dietary nor supplement intake were associated with serum
calcium levels (results not shown), nor did we find an association
with more extreme (bottom and top 5%) values of dietary, total or
supplement intake (results not shown).
Table 2 shows the hazard ratios (HRs) for cardiovascular death
using different measurements of calcium. The fully adjusted model
shows an increased risk of overall CVD death for those in the
Figure 1. Adjusted dose-response association between daily dietary calcium intake and risk for cardiovascular death. Calcium intake
was coded using an RCS function with four knots arbitrarily located at the 0.05, 0.35, 0.65, and 0.95 percentile. Y-axis represents the adjusted hazard
ratio for cardiovascular death for any value of calcium supplement/dietary intake compared to individuals with 1000 mg per day intake. Dashed lines
are 95% confidence intervals. Knots are represented by dots.
doi:10.1371/journal.pone.0061037.g001
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bottom 5% of serum calcium compared to those in the mid 90%
(HR: 1.51 (95% CI: 1.03–2.22)). The association was also observed
for death due to IHD and AMI, though with lower precision. High
serum calcium (top 5%) was also, although not statistically
significantly, associated with increased IHD mortality (HR: 1.32
(95% CI 0.96–1.81)).
Dietary calcium intake was not associated with an increased risk
of cardiovascular death (Table 3). Changing the categories of
dietary calcium (,178, 178–348, 348–539, 539–764, 764–1105,
1105–1789, 1789+ mg/day) into more extreme groups did not
alter these findings (results not shown). The dose-response
association between dietary calcium intake and cardiovascular
death is also illustrated in Figure 1.
Calcium supplement use was unrelated to the risk of CVD death
(Table 2). Additional adjustment for frequency of calcium
supplement usage during the past month or waist circumference
instead of BMI did not alter these estimates (results not shown).
Stratification by vitamin D levels did not alter any of the findings
observed in Table 2 nor did excluding CCI from the models
(results not shown). The dose-response association between
supplemental calcium intake and cardiovascular death is also
illustrated in Figure 2.
In a sex-stratified analysis (Table 3), slightly different patterns
were observed for men and women. For women there was a
statistically significant increased risk of IHD death for those with
serum calcium levels in the top 5% compared to those in the mid
90%, whereas in men, serum calcium in the bottom 5% was
related to increased CVD and IHD mortality. Moreover, there
was also a statistically significant decreased risk of IHD death for
men with a total daily intake 1300–2000 mg/day compared to
those with total daily intake 1000–1300 mg/day, but there was no
association for calcium intake from diet only. However, the only
statistically significant interaction was seen for dietary calcium
intake and sex with an increased risk of CVD mortality for men
with a low intake (,1000 mg/day) compared to those with intake
1000–1300 mg/day in contrast to a protective effect for women
with low dietary calcium intake (Pinteraction = 0.025).
Discussion
This large cohort study evaluated the association between
calcium intake, serum calcium levels and different types of
cardiovascular death in both men and women, while taking into
account a large number of potential confounders, including serum
Table 3. Hazard Ratios and 95%Confidence Intervals for risk of cardiovascular death by serum, dietary, supplement, and total
calcium, stratified by sex.
Hazard Ratios and 95%Confidence Intervals (CI) for Death due
to: P for interaction
MEN WOMEN
Any CVD IHD Any CVD IHD Any CVD IHD
(ICD10:I00–I99) (ICD10: I20–I25) (ICD10:I00–I99) (ICD10: I20–I25) (ICD10:I00–I99) (ICD10: I20–I25)
Ionized serum calcium1, mmol/L
,1.16 1.85 (1.14–3.01) 2.32 (1.39–3.88) 1.23 (0.72–2.08) 1.53 (0.69–3.39)
1.16–1.31 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 0.637 0.306
1.31+ 0.93 (0.55–1.57) 0.87 (0.46–1.67) 1.33 (0.88–1.99) 1.72 (1.13–2.61)
Dietary calcium intake2 (SE), mg
,500 1.23 (0.79–1.90) 1.13 (0.66–1.96) 0.86 (0.58–1.28) 1.13 (0.57–2.21)
500–1000 1.06 (0.81–1.40) 0.99 (0.66–1.47) 0.86 (0.59–1.26) 1.03 (0.53–1.99)
1000–1300 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 0.025 0.525
.1300 0.78 (0.50–1.22) 0.60 (0.28–1.31) 1.10 (0.61–1.97) 0.96 (0.43–2.15)
Calcium supplement users2 (versus no
supplements)
0.81 (0.54–1.22) 0.78 (0.47–1.29) 0.85 (0.64–1.12) 0.98 (0.70–1.36) 0.580 0.403
Daily supplemental calcium intake2, mg
0 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 0.555 0.439
0–1000 0.78 (0.50–1.21) 0.75 (0.43–1.32) 0.90 (0.69–1.19) 1.07 (0.79–1.45)
1000–2000 0.89 (0.32–2.45) 1.01 (0.32–3.22) 0.65 (0.33–1.30) 0.67 (0.29–1.53)
$2000 1.44 (0.37–5.66) 0.91 (0.13–6.67) 0.82 (0.54–1.25) 0.93 (0.38–2.28)
Total daily calcium intake2, mg
,500 1.25 (0.79–1.97) 1.05 (0.61–1.82) 1.23 (0.86–1.74) 1.41 (0.83–2.39) 0.102 0.589
500–1000 1.14 (0.83–1.57) 1.03 (0.68–1.56) 1.01 (0.69–1.47) 1.20 (0.67–2.14)
1000–1300 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref)
1300–2000 0.81 (0.52–1.26) 0.49 (0.25–0.98) 0.85 (0.49–1.47) 0.73 (0.35–1.52)
.2000 1.01 (0.44–2.29) 0.98 (0.34–2.85) 0.84 (0.44–1.62) 0.92 (0.32–2.62)
1Adjusted for: age, race/ethnicity, poverty to income ratio, comorbidity index, serum vitamin D, alcohol consumption, smoking behaviour, vigorous physical activity, and
BMI.
2Adjusted for: age, race/ethnicity, poverty to income ratio, comorbidity index, serum vitamin D, alcohol consumption, smoking behaviour, vigorous physical activity,
total energy intake, and BMI.
doi:10.1371/journal.pone.0061037.t003
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vitamin D levels. Overall, we found an increased risk of
cardiovascular death when serum calcium levels were
,1.16 mmol/L compared to 1.16–1.31 mmol/L, but for women,
there was an increased IHD mortality among women with high
serum calcium levels (.1.31 mmol/L). No associations were
found between cardiovascular death and dietary or supplement
calcium intake. However, there was a protective effect for total
calcium intake of 1300–2000 mg/day and death from IHD
among men. No obvious differences were observed by serum levels
of vitamin D.
Calcium is known to be part of the aetiological pathways of
cardiovascular disease. For instance, coronary artery calcium
scores specify the presence of calcium in coronary arteries and are
indicative of atherosclerotic plaques and thus risk of cardiovascular
disease [33]. Nevertheless, calcium has mainly been studied in
relation to bone health and only more recently cardiovascular
safety was raised as a concern in osteoporosis management [34].
Two recent meta-analyses showed an increased risk of up to 31%
for incident AMI when comparing calcium supplement users
versus placebo [13,35]. In addition to calcium supplements, also
dietary intake and serum levels of calcium have been studied in
relation to incident cardiovascular disease. The most recent study,
based on the Heidelberg cohort of EPIC, showed an inverse
association between dietary and dairy calcium intake and risk of
AMI, but an increased risk among users of calcium supplements
[9].
All the above studies focused on incident cardiovascular disease
and suggest a role for calcium, nevertheless the findings for an
association with cardiovascular mortality have been less consistent
with very few studies investigating both serum levels as well as
dietary and supplement intake in both men and women [9,34]. At
an annual meeting of the American Association of Clinical
Endocrinologists it was recently concluded, based on a review of
all relevant articles published between 1992 and 2011, that there is
inconsistent evidence for an association between calcium supple-
mentation $500 mg/day and an increase in cardiovascular
mortality risk [36]. Moreover, in a cohort of patients with stable
coronary heart disease it was shown that high serum calcium levels
were strongly associated with mortality risk (HR for 4th versus 1st
quartile: 2.39 (95% CI: 1.22–4.66)) [1]. However, the association
between dietary calcium and cardiovascular death was evaluated
in a cohort of 23,366 Swedish men aged 45–79 years who did not
take any dietary supplements and showed a non-statistically
significant lower rate of cardiovascular death (HR: 0.77 (95% CI:
0.58–1.01) when comparing the highest intake tertile
($1,599 mg/day) to the lowest (,1,230 mg/day) [11]).
Our study thus assessed three different measurements of
calcium and partly corroborates previous findings. In terms of
serum calcium, we found a positive association between low serum
calcium levels and cardiovascular death, which was confined to
men, as well as high levels and IHD death for women. This finding
may have been obscured in previous studies due to larger serum
calcium categories or the focus on a specific patient population
such as chronic kidney disease patients [6]. Since the test for
interaction by sex was not statistically significant this finding may
simply be due to chance. We did not find an overall association
between dietary or supplement calcium intake and cardiovascular
mortality, which is in contrast with the most recent study based on
the NIH AARP-Diet and Health study [8]. This study and our
study both adjusted for a wide range of potential confounders and
Figure 2. Adjusted dose-response association between daily calcium supplement intake and risk for cardiovascular death. Calcium
supplement intake was coded using an RCS function with four knots arbitrarily located at the 0.05, 0.35, 0.65, and 0.95 percentile. Y-axis represents
the adjusted hazard ratio for cardiovascular death for any value of calcium supplement/dietary intake compared to individuals with 0 mg per day
intake. Dashed lines are 95% confidence intervals. Knots are represented by dots.
doi:10.1371/journal.pone.0061037.g002
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have comparably long follow-up, but it is possible that differences
in assessment of supplement intake explain the inconsistent
findings between both studies.
The main strength of this study is its generalizibility as it uses
nationally representative data including both men and women. In
addition, we were able to take into account many potential
confounding factors and perform stratified analyses by sex and
vitamin D levels. Repeated measurement could have strengthened
the accuracy of different calcium measurements as a single
measurement may be prone to measurement error and within-
person variation. Dietary calcium intake was assessed using a
single 24-hour recall, which may not reflect a participant’s
habitual diet. Supplement intake in NHANES III is self-reported
but the recording of the supplement name from the label is a
strength compared with many other studies. Nevertheless, given
the complexity of supplements data collection may be subject to
some error and the analytic verification of the supplement’s actual
content would be required to accurately measure the levels of
calcium intake [37]. Despite its relative large sample size, we
lacked power for some of the stratified analyses and could not
perform a stratified analysis for the association between dietary or
supplement calcium intake and cardiovascular mortality by serum
calcium levels according to the extreme cut-offs used.
Conclusion
The current study suggests that calcium is involved in
cardiovascular health. However there was no strong evidence for
an association between calcium supplement usage and cardiovas-
cular death indicating that calcium supplement usage may be a
marker of healthy life style despite adjustments for comorbidities,
smoking, alcohol consumption, and levels of physical activity.
However, it is possible that calcium supplementation may have a
different effect on incident cardiovascular disease than on fatal
cardiovascular disease. Whether extremely low or extremely high
serum concentrations of calcium are related to cardiovascular
mortality, in particular IHD, and whether these associations differ
by sex needs to be addressed in future studies in which these
markers of calcium are assessed in detail.
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